40 0 2 0 2 B-lower_bound
- 3 4 3 4 O
64 5 7 5 7 B-upper_bound
years 8 13 8 13 I-upper_bound
of 14 16 14 16 O
age 17 20 17 20 B-age

Diagnosis 0 9 21 30 O
of 10 12 31 33 O
any 13 16 34 37 O
other 17 22 38 43 O
neurologic 23 33 44 54 B-chronic_disease
disease 34 41 55 62 I-chronic_disease

Diagnosis 0 9 63 72 O
of 10 12 73 75 O
idiopathic 13 23 76 86 B-chronic_disease
Parkinson 24 33 87 96 I-chronic_disease
's 33 35 96 98 I-chronic_disease
disease 36 43 99 106 I-chronic_disease
that 44 48 107 111 O
is 49 51 112 114 O
optimally 52 61 115 124 O
treated 62 69 125 132 O
( 70 71 133 134 O
motor 71 76 134 139 B-clinical_variable
fluctuations 77 89 140 152 I-clinical_variable
< 90 91 153 154 O
20 91 93 154 156 B-upper_bound
% 93 94 156 157 I-upper_bound
of 95 97 158 160 O
subject 98 105 161 168 O
's 105 107 168 170 O
awake 108 113 171 176 O
time 114 118 177 181 O
) 118 119 181 182 O

Diagnosis 0 9 183 192 O
of 10 12 193 195 O
moderate 13 21 196 204 O
erectile 22 30 205 213 B-chronic_disease
dysfunction 31 42 214 225 I-chronic_disease
( 43 44 226 227 O
defined 44 51 227 234 O
according 52 61 235 244 O
to 62 64 245 247 O
the 65 68 248 251 O
NIH 69 72 252 255 O
Consensus 73 82 256 265 O
Development 83 94 266 277 O
Panel 95 100 278 283 O
on 101 103 284 286 O
Impotence 104 113 287 296 O
) 113 114 296 297 O
for 115 118 298 301 O
more 119 123 302 306 O
than 124 128 307 311 O
6 129 130 312 313 B-lower_bound
months 131 137 314 320 I-lower_bound
and 138 141 321 324 O
demonstrating 142 155 325 338 O
and 156 159 339 342 O
incomplete 160 170 343 353 O
response 171 179 354 362 O
to 180 182 363 365 O
tadalafil 183 192 366 375 B-treatment
alone 193 198 376 381 O

Hoehn 0 5 382 387 B-clinical_variable
and 6 9 388 391 I-clinical_variable
Yahr 10 14 392 396 I-clinical_variable
Scale 15 20 397 402 I-clinical_variable
score 21 26 403 408 I-clinical_variable
of 27 29 409 411 O
1 30 31 412 413 B-lower_bound
- 32 33 414 415 O
3 34 35 416 417 B-upper_bound

Sexually 0 8 418 426 O
active 9 15 427 433 O
( 16 17 434 435 O
i.e. 17 21 435 439 O
≥1 22 24 440 442 O
attempt 25 32 443 450 I-lower_bound
/ 32 33 450 451 I-lower_bound
week 33 37 451 455 I-lower_bound
) 37 38 455 456 O
males 39 44 457 462 B-gender

Subject 0 7 463 470 O
demonstrating 8 21 471 484 O
an 22 24 485 487 O
IIEF-5 25 31 488 494 B-clinical_variable
drug 32 36 495 499 I-clinical_variable
- 36 37 499 500 I-clinical_variable
free 37 41 500 504 I-clinical_variable
baseline 42 50 505 513 I-clinical_variable
score 51 56 514 519 I-clinical_variable
that 57 61 520 524 O
is 62 64 525 527 O
≥ 65 66 528 529 O
10 67 69 530 532 B-lower_bound
but 70 73 533 536 O
≤ 74 75 537 538 O
16 76 78 539 541 B-upper_bound

Subject 0 7 542 549 O
in 8 10 550 552 O
a 11 12 553 554 O
stable 13 19 555 561 O
heterosexual 20 32 562 574 O
relationship 33 45 575 587 O
for 46 49 588 591 O
at 50 52 592 594 O
least 53 58 595 600 O
6 59 60 601 602 B-lower_bound
months 61 67 603 609 I-lower_bound

Subject 0 7 610 617 O
motivated 8 17 618 627 O
to 18 20 628 630 O
seek 21 25 631 635 O
treatment 26 35 636 645 B-treatment
for 36 39 646 649 O
erectile 40 48 650 658 B-chronic_disease
dysfunction 49 60 659 670 I-chronic_disease

Subject 0 7 671 678 O
with 8 12 679 683 O
a 13 14 684 685 O
bleeding 15 23 686 694 B-chronic_disease
disorder 24 32 695 703 I-chronic_disease

Subject 0 7 704 711 O
with 8 12 712 716 O
a 13 14 717 718 O
history 15 22 719 726 O
of 23 25 727 729 O
a 26 27 730 731 O
positive 28 36 732 740 O
test 37 41 741 745 O
for 42 45 746 749 O
Hepatitis 46 55 750 759 B-chronic_disease
B 56 57 760 761 I-chronic_disease
surface 58 65 762 769 I-chronic_disease
antigen 66 73 770 777 I-chronic_disease
( 74 75 778 779 I-chronic_disease
HbsAg 75 80 779 784 I-chronic_disease
) 80 81 784 785 I-chronic_disease
or 82 84 786 788 O
Hepatitis 85 94 789 798 B-chronic_disease
C 95 96 799 800 I-chronic_disease

Subject 0 7 801 808 O
with 8 12 809 813 O
a 13 14 814 815 O
history 15 22 816 823 O
of 23 25 824 826 O
congenital 26 36 827 837 B-chronic_disease
QT 37 39 838 840 I-chronic_disease
prolongation 40 52 841 853 I-chronic_disease

Subject 0 7 854 861 O
with 8 12 862 866 O
a 13 14 867 868 O
history 15 22 869 876 O
of 23 25 877 879 O
loss 26 30 880 884 B-chronic_disease
of 31 33 885 887 I-chronic_disease
vision 34 40 888 894 I-chronic_disease
because 41 48 895 902 O
of 49 51 903 905 O
non 52 55 906 909 B-chronic_disease
- 55 56 909 910 I-chronic_disease
arteritic 56 65 910 919 I-chronic_disease
anterior 66 74 920 928 I-chronic_disease
ischemic 75 83 929 937 I-chronic_disease
optic 84 89 938 943 I-chronic_disease
neuropathy 90 100 944 954 I-chronic_disease
( 101 102 955 956 I-chronic_disease
NAION 102 107 956 961 I-chronic_disease
) 107 108 961 962 I-chronic_disease

Subject 0 7 963 970 O
with 8 12 971 975 O
a 13 14 976 977 O
history 15 22 978 985 O
of 23 25 986 988 O
malignancy 26 36 989 999 B-cancer
within 37 43 1000 1006 O
the 44 47 1007 1010 O
past 48 52 1011 1015 B-upper_bound
5 53 54 1016 1017 I-upper_bound
years 55 60 1018 1023 I-upper_bound
( 61 62 1024 1025 O
other 62 67 1025 1030 O
than 68 72 1031 1035 O
squamous 73 81 1036 1044 B-cancer
or 82 84 1045 1047 O
basal 85 90 1048 1053 B-cancer
cell 91 95 1054 1058 I-cancer
skin 96 100 1059 1063 I-cancer
cancer 101 107 1064 1070 I-cancer
) 107 108 1070 1071 O

Subject 0 7 1072 1079 O
with 8 12 1080 1084 O
a 13 14 1085 1086 O
history 15 22 1087 1094 O
of 23 25 1095 1097 O
myocardial 26 36 1098 1108 B-chronic_disease
infarction 37 47 1109 1119 I-chronic_disease
, 47 48 1119 1120 O
stroke 49 55 1121 1127 B-chronic_disease
or 56 58 1128 1130 O
life 59 63 1131 1135 O
- 63 64 1135 1136 O
threatening 64 75 1136 1147 O
arrhythmia 76 86 1148 1158 B-chronic_disease
within 87 93 1159 1165 O
6 94 95 1166 1167 B-upper_bound
months 96 102 1168 1174 I-upper_bound
prior 103 108 1175 1180 I-upper_bound
to 109 111 1181 1183 O
screening 112 121 1184 1193 O

Subject 0 7 1194 1201 O
with 8 12 1202 1206 O
a 13 14 1207 1208 O
history 15 22 1209 1216 O
of 23 25 1217 1219 O
prostatectomy 26 39 1220 1233 B-treatment
because 40 47 1234 1241 O
of 48 50 1242 1244 O
prostate 51 59 1245 1253 B-cancer
cancer 60 66 1254 1260 I-cancer
, 66 67 1260 1261 O
including 68 77 1262 1271 O
nerve 78 83 1272 1277 O
sparing 84 91 1278 1285 O
techniques 92 102 1286 1296 O

Subject 0 7 1297 1304 O
with 8 12 1305 1309 O
a 13 14 1310 1311 O
history 15 22 1312 1319 O
of 23 25 1320 1322 O
syncope 26 33 1323 1330 B-chronic_disease
within 34 40 1331 1337 O
the 41 44 1338 1341 O
last 45 49 1342 1346 B-upper_bound
6 50 51 1347 1348 I-upper_bound
months 52 58 1349 1355 I-upper_bound
prior 59 64 1356 1361 I-upper_bound
to 65 67 1362 1364 O
screening 68 77 1365 1374 O

Subject 0 7 1375 1382 O
with 8 12 1383 1387 O
a 13 14 1388 1389 O
known 15 20 1390 1395 O
hypersensitivity 21 37 1396 1412 O
to 38 40 1413 1415 O
any 41 44 1416 1419 O
component 45 54 1420 1429 O
of 55 57 1430 1432 O
the 58 61 1433 1436 O
investigational 62 77 1437 1452 B-allergy_name
medications 78 89 1453 1464 I-allergy_name
, 89 90 1464 1465 O
monoamine 91 100 1466 1475 B-allergy_name
oxidase 101 108 1476 1483 I-allergy_name
inhibitors 109 119 1484 1494 I-allergy_name
, 119 120 1494 1495 O
phosphodiesterase 121 138 1496 1513 B-allergy_name
type 139 143 1514 1518 I-allergy_name
5 144 145 1519 1520 I-allergy_name
inhibitors 146 156 1521 1531 I-allergy_name
or 157 159 1532 1534 O
phenylethylamines 160 177 1535 1552 B-allergy_name

Subject 0 7 1553 1560 O
with 8 12 1561 1565 O
a 13 14 1566 1567 O
penile 15 21 1568 1574 B-chronic_disease
anatomical 22 32 1575 1585 I-chronic_disease
abnormality 33 44 1586 1597 I-chronic_disease
( 45 46 1598 1599 O
e.g. 46 50 1599 1603 O
, 50 51 1603 1604 O
penile 52 58 1605 1611 B-chronic_disease
fibrosis 59 67 1612 1620 I-chronic_disease
, 67 68 1620 1621 O
fractures 69 78 1622 1631 O
, 78 79 1631 1632 O
or 80 82 1633 1635 O
Peyronie 83 91 1636 1644 B-chronic_disease
's 91 93 1644 1646 I-chronic_disease
disease 94 101 1647 1654 I-chronic_disease
) 101 102 1654 1655 O
which 103 108 1656 1661 O
, 108 109 1661 1662 O
in 110 112 1663 1665 O
the 113 116 1666 1669 O
investigator 117 129 1670 1682 O
's 129 131 1682 1684 O
opinion 132 139 1685 1692 O
, 139 140 1692 1693 O
could 141 146 1694 1699 O
significantly 147 160 1700 1713 O
impair 161 167 1714 1720 O
sexual 168 174 1721 1727 O
performance 175 186 1728 1739 O

Subject 0 7 1740 1747 O
with 8 12 1748 1752 O
a 13 14 1753 1754 O
severe 15 21 1755 1761 O
chronic 22 29 1762 1769 B-chronic_disease
or 30 32 1770 1772 I-chronic_disease
acute 33 38 1773 1778 I-chronic_disease
liver 39 44 1779 1784 I-chronic_disease
disease 45 52 1785 1792 I-chronic_disease
, 52 53 1792 1793 O
history 54 61 1794 1801 O
of 62 64 1802 1804 O
moderate 65 73 1805 1813 O
( 74 75 1814 1815 O
Child 75 80 1815 1820 B-chronic_disease
- 80 81 1820 1821 I-chronic_disease
Pugh 81 85 1821 1825 I-chronic_disease
B 86 87 1826 1827 I-chronic_disease
) 87 88 1827 1828 O
, 88 89 1828 1829 O
or 90 92 1830 1832 O
severe 93 99 1833 1839 O
( 100 101 1840 1841 O
Child 101 106 1841 1846 B-chronic_disease
- 106 107 1846 1847 I-chronic_disease
Pugh 107 111 1847 1851 I-chronic_disease
C 112 113 1852 1853 I-chronic_disease
) 113 114 1853 1854 O
hepatic 115 122 1855 1862 B-chronic_disease
impairment 123 133 1863 1873 I-chronic_disease

Subject 0 7 1874 1881 O
with 8 12 1882 1886 O
a 13 14 1887 1888 O
total 15 20 1889 1894 B-clinical_variable
serum 21 26 1895 1900 I-clinical_variable
testosterone 27 39 1901 1913 I-clinical_variable
level 40 45 1914 1919 I-clinical_variable
≥ 46 47 1920 1921 O
300 48 51 1922 1925 B-lower_bound
ng 52 54 1926 1928 I-lower_bound
/ 54 55 1928 1929 I-lower_bound
dL 55 57 1929 1931 I-lower_bound
, 57 58 1931 1932 O
with 59 63 1933 1937 O
or 64 66 1938 1940 O
without 67 74 1941 1948 O
supplementation 75 90 1949 1964 O

Subject 0 7 1965 1972 O
with 8 12 1973 1977 O
active 13 19 1978 1984 O
peptic 20 26 1985 1991 B-chronic_disease
ulceration 27 37 1992 2002 I-chronic_disease

Subject 0 7 2003 2010 O
with 8 12 2011 2015 O
any 13 16 2016 2019 O
underlying 17 27 2020 2030 O
cardiovascular 28 42 2031 2045 B-chronic_disease
condition 43 52 2046 2055 I-chronic_disease
, 52 53 2055 2056 O
including 54 63 2057 2066 O
unstable 64 72 2067 2075 B-chronic_disease
angina 73 79 2076 2082 I-chronic_disease
pectoris 80 88 2083 2091 I-chronic_disease
, 88 89 2091 2092 O
which 90 95 2093 2098 O
preclude 96 104 2099 2107 O
sexual 105 111 2108 2114 O
activity 112 120 2115 2123 O

Subject 0 7 2124 2131 O
with 8 12 2132 2136 O
clinically 13 23 2137 2147 O
significant 24 35 2148 2159 O
chronic 36 43 2160 2167 B-chronic_disease
hematological 44 57 2168 2181 I-chronic_disease
disease 58 65 2182 2189 I-chronic_disease
which 66 71 2190 2195 O
could 72 77 2196 2201 O
lead 78 82 2202 2206 O
to 83 85 2207 2209 O
priapism 86 94 2210 2218 B-chronic_disease
such 95 99 2219 2223 O
as 100 102 2224 2226 O
sickle 103 109 2227 2233 B-chronic_disease
cell 110 114 2234 2238 I-chronic_disease
anemia 115 121 2239 2245 I-chronic_disease
, 121 122 2245 2246 O
multiple 123 131 2247 2255 B-cancer
myeloma 132 139 2256 2263 I-cancer
, 139 140 2263 2264 O
and 141 144 2265 2268 O
leukemia 145 153 2269 2277 B-cancer

Subject 0 7 2278 2285 O
with 8 12 2286 2290 O
hereditary 13 23 2291 2301 O
degenerative 24 36 2302 2314 B-chronic_disease
retinal 37 44 2315 2322 I-chronic_disease
disorders 45 54 2323 2332 I-chronic_disease
such 55 59 2333 2337 O
as 60 62 2338 2340 O
retinitis 63 72 2341 2350 B-chronic_disease
pigmentosa 73 83 2351 2361 I-chronic_disease

Subject 0 7 2362 2369 O
with 8 12 2370 2374 O
hypotension 13 24 2375 2386 O
and 25 28 2387 2390 O
a 29 30 2391 2392 O
resting 31 38 2393 2400 O
systolic 39 47 2401 2409 B-clinical_variable
blood 48 53 2410 2415 I-clinical_variable
pressure 54 62 2416 2424 I-clinical_variable
of 63 65 2425 2427 O
< 66 67 2428 2429 O
90 68 70 2430 2432 B-upper_bound
mmHG 71 75 2433 2437 I-upper_bound

Subject 0 7 2438 2445 O
with 8 12 2446 2450 O
symptomatic 13 24 2451 2462 O
postural 25 33 2463 2471 B-chronic_disease
hypotension 34 45 2472 2483 I-chronic_disease
( 46 47 2484 2485 O
severe 47 53 2485 2491 O
dizziness 54 63 2492 2501 O
or 64 66 2502 2504 O
fainting 67 75 2505 2513 O

Subject 0 7 2514 2521 O
with 8 12 2522 2526 O
uncontrolled 13 25 2527 2539 O
atrial 26 32 2540 2546 B-chronic_disease
fibrillation 33 45 2547 2559 I-chronic_disease
/ 45 46 2559 2560 O
flutter 46 53 2560 2567 O
at 54 56 2568 2570 O
screening 57 66 2571 2580 O
( 67 68 2581 2582 O
defined 68 75 2582 2589 O
as 76 78 2590 2592 O
ventricular 79 90 2593 2604 B-clinical_variable
response 91 99 2605 2613 I-clinical_variable
rate 100 104 2614 2618 I-clinical_variable
≥ 105 106 2619 2620 O
100 107 110 2621 2624 B-lower_bound
bpm 111 114 2625 2628 I-lower_bound
) 114 115 2628 2629 O

Subjects 0 8 2630 2638 O
currently 9 18 2639 2648 O
consuming 19 28 2649 2658 O
≥5 29 31 2659 2661 O
units 32 37 2662 2667 I-lower_bound
of 38 40 2668 2670 O
alcohol 41 48 2671 2678 O
per 49 52 2679 2682 O
day 53 56 2683 2686 O

Subjects 0 8 2687 2695 O
may 9 12 2696 2699 O
be 13 15 2700 2702 O
on 16 18 2703 2705 O
levodopa 19 27 2706 2714 B-treatment
therapy 28 35 2715 2722 I-treatment
but 36 39 2723 2726 O
must 40 44 2727 2731 O
be 45 47 2732 2734 O
stable 48 54 2735 2741 O
at 55 57 2742 2744 O
the 58 61 2745 2748 O
time 62 66 2749 2753 O
of 67 69 2754 2756 O
entry 70 75 2757 2762 O
into 76 80 2763 2767 O
the 81 84 2768 2771 O
study 85 90 2772 2777 O

Subjects 0 8 2778 2786 O
with 9 13 2787 2791 O
a 14 15 2792 2793 O
history 16 23 2794 2801 O
of 24 26 2802 2804 O
drug 27 31 2805 2809 O
or 32 34 2810 2812 O
alcohol 35 42 2813 2820 O
abuse 43 48 2821 2826 O
within 49 55 2827 2833 O
the 56 59 2834 2837 O
past 60 64 2838 2842 B-upper_bound
6 65 66 2843 2844 I-upper_bound
months 67 73 2845 2851 I-upper_bound

Uncontrolled 0 12 2852 2864 B-chronic_disease
Diabetes 13 21 2865 2873 I-chronic_disease
( 22 23 2874 2875 O
Hemoglobin 23 33 2875 2885 B-clinical_variable
A1C 34 37 2886 2889 I-clinical_variable
> 38 39 2890 2891 O
7.5 40 43 2892 2895 B-lower_bound
) 43 44 2895 2896 O

an 0 2 2897 2899 O
IIEF-5 3 9 2900 2906 B-clinical_variable
tadalafil 10 19 2907 2916 B-treatment
- 19 20 2916 2917 O
alone 20 25 2917 2922 O
baseline 26 34 2923 2931 O
score 35 40 2932 2937 O
that 41 45 2938 2942 O
is 46 48 2943 2945 O
≤ 49 50 2946 2947 O
18 51 53 2948 2950 B-upper_bound

cryosurgery 0 11 2951 2962 B-treatment
, 11 12 2962 2963 O
cryotherapy 13 24 2964 2975 B-treatment
or 25 27 2976 2978 O
cryoablation 28 40 2979 2991 B-treatment

hypertension 0 12 2992 3004 B-chronic_disease
with 13 17 3005 3009 O
a 18 19 3010 3011 O
resting 20 27 3012 3019 O
systolic 28 36 3020 3028 B-clinical_variable
blood 37 42 3029 3034 I-clinical_variable
pressure 43 51 3035 3043 I-clinical_variable
> 52 53 3044 3045 O
170 54 57 3046 3049 B-lower_bound
mmHG 58 62 3050 3054 I-lower_bound
or 63 65 3055 3057 O
a 66 67 3058 3059 O
resting 68 75 3060 3067 O
diastolic 76 85 3068 3077 B-clinical_variable
blood 86 91 3078 3083 I-clinical_variable
pressure 92 100 3084 3092 I-clinical_variable
> 101 102 3093 3094 O
110 103 106 3095 3098 B-lower_bound
mmHG 107 111 3099 3103 I-lower_bound

receiving 0 9 3104 3113 O
dopamine 10 18 3114 3122 B-treatment
agonists 19 27 3123 3131 I-treatment
, 27 28 3131 3132 O
nitrates 29 37 3133 3141 B-treatment
, 37 38 3141 3142 O
alpha 39 44 3143 3148 B-treatment
- 44 45 3148 3149 I-treatment
receptor 45 53 3149 3157 I-treatment
blocking 54 62 3158 3166 I-treatment
agents 63 69 3167 3173 I-treatment
, 69 70 3173 3174 O
or 71 73 3175 3177 O
antihypertensive 74 90 3178 3194 B-treatment
medication 91 101 3195 3205 I-treatment
( 102 103 3206 3207 O
see 103 106 3207 3210 O
other 107 112 3211 3216 O
exclusionary 113 125 3217 3229 O
medications 126 137 3230 3241 O
listed 138 144 3242 3248 O
below 145 150 3249 3254 O
) 150 151 3254 3255 O

unwilling 0 9 3256 3265 O
to 10 12 3266 3268 O
cease 13 18 3269 3274 O
use 19 22 3275 3278 O
of 23 25 3279 3281 O
any 26 29 3282 3285 O
treatment 30 39 3286 3295 B-treatment
for 40 43 3296 3299 O
erectile 44 52 3300 3308 B-chronic_disease
dysfunction 53 64 3309 3320 I-chronic_disease
during 65 71 3321 3327 O
the 72 75 3328 3331 O
study 76 81 3332 3337 O
, 81 82 3337 3338 O
including 83 92 3339 3348 O
oral 93 97 3349 3353 B-treatment
medication 98 108 3354 3364 I-treatment
, 108 109 3364 3365 O
vacuum 110 116 3366 3372 B-treatment
devices 117 124 3373 3380 I-treatment
, 124 125 3380 3381 O
constrictive 126 138 3382 3394 B-treatment
devices 139 146 3395 3402 I-treatment
, 146 147 3402 3403 O
injections 148 158 3404 3414 B-treatment
, 158 159 3414 3415 O
urethral 160 168 3416 3424 B-treatment
suppositories 169 182 3425 3438 I-treatment
, 182 183 3438 3439 O
gels 184 188 3440 3444 B-treatment
, 188 189 3444 3445 O
any 190 193 3446 3449 O
over 194 198 3450 3454 B-treatment
- 198 199 3454 3455 I-treatment
the 199 202 3455 3458 I-treatment
- 202 203 3458 3459 I-treatment
counter 203 210 3459 3466 I-treatment
or 211 213 3467 3469 I-treatment
nonprescription 214 229 3470 3485 I-treatment
medications 230 241 3486 3497 I-treatment
, 241 242 3497 3498 O
and 243 246 3499 3502 O
products 247 255 3503 3511 O
purchased 256 265 3512 3521 O
via 266 269 3522 3525 O
the 270 273 3526 3529 O
internet 274 282 3530 3538 O

